Sanofi India · NSE: SANOFI · BSE: 500674
Q3 FY21 results · Oct–Dec 2020
Sanofi India reported revenue from operations of ₹720.30 crore (down 12.8% from Q3 FY20) and net profit of ₹123.00 crore (up 26.4% from Q3 FY20) for Q3 FY21 (Oct–Dec 2020), on a standalone basis.
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 720.30 | 826.30 | −12.8% | 686.60 | +4.9% |
| Other income | 16.20 | 24.80 | −34.7% | 14.90 | +8.7% |
| Total income | 736.50 | 851.10 | −13.5% | 701.50 | +5.0% |
| Profit before tax | 170.20 | 161.30 | +5.5% | 185.90 | −8.4% |
| Net profit for the period | 123.00 | 97.30 | +26.4% | 132.90 | −7.4% |
| EPS, basic (₹) | 53.41 | 42.26 | +26.4% | 57.71 | −7.5% |
| Net margin (%) | 17.1 | 11.8 | 19.4 |
Standalone
- Filed with BSE
- 24 Feb 2021, 17:45 IST
- Board meeting
- 23 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Audited
- Source
- XBRL filing on BSE